BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35971329)

  • 21. The deubiquitinating enzyme Usp14 allosterically inhibits multiple proteasomal activities and ubiquitin-independent proteolysis.
    Kim HT; Goldberg AL
    J Biol Chem; 2017 Jun; 292(23):9830-9839. PubMed ID: 28416611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging role of ubiquitin-specific protease 14 in oncogenesis and development of tumor: Therapeutic implication.
    Liu B; Chen J; Zhang S
    Life Sci; 2019 Dec; 239():116875. PubMed ID: 31676235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteasome-associated cysteine deubiquitinases are molecular targets of environmental optical brightener compounds.
    Castro I; Ekinci E; Huang X; Cheaito HA; Ahn YH; Olivero-Verbel J; Dou QP
    J Cell Biochem; 2019 Aug; 120(8):14065-14075. PubMed ID: 30963630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasomal deubiquitylase activity enhances cell surface recycling of the epidermal growth factor receptor in non-small cell lung cancer.
    Wang S; Wang T; Yang Q; Cheng S; Liu F; Yang G; Wang F; Wang R; Yang D; Zhou M; Duan C; Zhang Y; Liu H; Dai Z; Tian K; Liu S
    Cell Oncol (Dordr); 2022 Oct; 45(5):951-965. PubMed ID: 36129611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquitin-specific protease 14 regulates c-Jun N-terminal kinase signaling at the neuromuscular junction.
    Vaden JH; Bhattacharyya BJ; Chen PC; Watson JA; Marshall AG; Phillips SE; Wilson JA; King GD; Miller RJ; Wilson SM
    Mol Neurodegener; 2015 Jan; 10():3. PubMed ID: 25575639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro analysis of proteasome-associated USP14 activity for substrate degradation and deubiquitylation.
    Muniyappan S; Lee BH
    Methods Enzymol; 2019; 619():249-268. PubMed ID: 30910023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor.
    Liao Y; Liu N; Hua X; Cai J; Xia X; Wang X; Huang H; Liu J
    Cell Death Dis; 2017 Feb; 8(2):e2585. PubMed ID: 28151478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Deubiquitinating Enzyme USP14 Regulates Leukemic Chemotherapy Drugs-Induced Cell Apoptosis by Suppressing Ubiquitination of Aurora Kinase B.
    Song C; Ma R; Yang X; Pang S
    Cell Physiol Biochem; 2017; 42(3):965-973. PubMed ID: 28662510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of proteasome activity by a small-molecule inhibitor of USP14.
    Lee BH; Lee MJ; Park S; Oh DC; Elsasser S; Chen PC; Gartner C; Dimova N; Hanna J; Gygi SP; Wilson SM; King RW; Finley D
    Nature; 2010 Sep; 467(7312):179-84. PubMed ID: 20829789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage.
    Zhang X; Pellegrini P; Saei AA; Hillert EK; Mazurkiewicz M; Olofsson MH; Zubarev RA; D'Arcy P; Linder S
    Biochem Pharmacol; 2018 Oct; 156():291-301. PubMed ID: 30149015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma.
    Yu Y; Zhao Y; Fan Y; Chen Z; Li H; Lu J; Guo K; Woodfield SE; Vasudevan SA; Yang J; Nuchtern JG
    Mol Cancer Ther; 2019 Jun; 18(6):1045-1056. PubMed ID: 30962318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC).
    Morgan EL; Toni T; Viswanathan R; Robbins Y; Yang X; Cheng H; Gunti S; Huynh A; Sowers AL; Mitchell JB; Allen CT; Chen Z; Van Waes C
    Cell Death Differ; 2023 May; 30(5):1382-1396. PubMed ID: 37055579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies.
    Didier R; Mallavialle A; Ben Jouira R; Domdom MA; Tichet M; Auberger P; Luciano F; Ohanna M; Tartare-Deckert S; Deckert M
    Mol Cancer Ther; 2018 Jul; 17(7):1416-1429. PubMed ID: 29703842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The deubiquitinase UCHL5/UCH37 positively regulates Hedgehog signaling by deubiquitinating Smoothened.
    Zhou Z; Yao X; Pang S; Chen P; Jiang W; Shan Z; Zhang Q
    J Mol Cell Biol; 2018 Jun; 10(3):243-257. PubMed ID: 28992318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity.
    Walters BJ; Campbell SL; Chen PC; Taylor AP; Schroeder DG; Dobrunz LE; Artavanis-Tsakonas K; Ploegh HL; Wilson JA; Cox GA; Wilson SM
    Mol Cell Neurosci; 2008 Dec; 39(4):539-48. PubMed ID: 18771733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death.
    Wang X; Stafford W; Mazurkiewicz M; Fryknäs M; Brjnic S; Zhang X; Gullbo J; Larsson R; Arnér ES; D'Arcy P; Linder S
    Mol Pharmacol; 2014 Jun; 85(6):932-45. PubMed ID: 24714215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFβ-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis.
    Nan L; Jacko AM; Tan J; Wang D; Zhao J; Kass DJ; Ma H; Zhao Y
    Sci Rep; 2016 Sep; 6():33116. PubMed ID: 27604640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USP14 deubiquitinates proteasome-bound substrates that are ubiquitinated at multiple sites.
    Lee BH; Lu Y; Prado MA; Shi Y; Tian G; Sun S; Elsasser S; Gygi SP; King RW; Finley D
    Nature; 2016 Apr; 532(7599):398-401. PubMed ID: 27074503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteasome-Bound UCH37/UCHL5 Debranches Ubiquitin Chains to Promote Degradation.
    Deol KK; Crowe SO; Du J; Bisbee HA; Guenette RG; Strieter ER
    Mol Cell; 2020 Dec; 80(5):796-809.e9. PubMed ID: 33156996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug.
    Zhang X; Selvaraju K; Saei AA; D'Arcy P; Zubarev RA; Arnér ES; Linder S
    Biochimie; 2019 Jul; 162():46-54. PubMed ID: 30946948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.